The Cooper Companies, Inc. (COO)
NASDAQ
Closed
Oct 8, 2026
Day's Range
53.7152 wk Range
51.01Overview - COO - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
13.46B
P/E (Trailing)
‪19.55‬
P/E (Forward)
‪12.12‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪2.55‬
Price / Book
‪1.29‬
EV / EBITDA
‪14.45‬
Profitability
Gross Margin
‪66.76%‬
Profit Margin
‪13.46%‬
Operating Margin
‪20.82%‬
Return on Assets
‪2.73%‬
Return on Equity
‪6.83%‬
Ownership
Shares Outstanding
190.10M
Float
188.76M
Short % of Shares Outstanding
‪6.03%‬
Held by Insiders
‪0.63%‬
Held by Institutions
‪111.91%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪67.23‬
200-Day Avg
‪71.50‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Semi-Annual
Analyst Consensus
16 analysts
Average price target
‪$ 81.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - COO - The Cooper Companies, Inc.
Peers - COO - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - COO - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
